The neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) cau
ses, via its metabolite 1-methyl-4-phenylpyridinium (MPP+), parkinsoni
sm in humans, monkeys, and mice but not in rats. When incubated with m
ouse brain homogenates, [H-3]-MPP+ is recovered in relatively large co
ncentrations in the brain cell nucleus. Although isolated cell nuclei
from rat and mouse brain contain uptake systems for dopamine (DA), onl
y brain cell nuclei from mice avidly take up [H-3]MPP+. This nuclear u
ptake is ATP dependent and can be blocked by ouabain and N-ethylmaleim
ide. It is not, however, affected by neuronal and vesicular blockers s
uch as benztropine, mazindol, and reserpine. Selective uptake of MPPinto brain Gell nuclei may provide a new avenue for future investigati
on into the complex modes of action of the neurotoxin MPTP.